|
Bristol-Myers 4Q net rises 9 pct on cost cuts
NewsOK.com Rheumatoid arthritis drug Orencia’s sales rose 26 percent to $325 million and sales jumped 47 percent to $211 million for breakthrough melanoma drug Yervoy. However, transplant rejection drug Nulojix, approved in June 2011, generated just $4 million in … |
|
“Xeljanz (Tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis …
SBWire (press release) Pfizer has developed Xeljanz (tofacitinib;formerly known as tasocitinib), an oral, small-molecule inhibitor of JAK3 kinase for the treatment of RA, psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, transplant … |
|
Bristol-Myers 4Q net rises 9 pct on cost cuts
San Antonio Express However, transplant rejection drug Nulojix, approved in June 2011, generated just $4 million in the fourth quarter and $11 million for all of 2012. “Bristol-Myers Squibb had a strong finish to an important year of transition,” CEO Lamberto Andreotti … |
|
Research and Markets: Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast …
PharmiWeb.com (press release) Pfizer has developed Xeljanz (tofacitinib;formerly known as tasocitinib), an oral, small-molecule inhibitor of JAK3 kinase for the treatment of RA, psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, transplant … |
First Coast NewsThere are several foods that can affect medicationFirst Coast NewsGrapefruit juice: Some statin drugs to lower cholesterol, such as simvastatin (Zocor), atorvastatin (Lipitor), and pravastatin (Pravachol); some blood pressure-lowering d…
Grapefruit not only food that can affect medicationCincinnati.comGrapefruit juice: Some statin drugs to lower cholesterol, such as simvastatin (Zocor), atorvastatin (Lipitor), and pravastatin (Pravachol); some blood pressure-lowering drugs, such as Nif…
Grapefruit not only food that can affect medicationUSA TODAYGrapefruit juice: Some statin drugs to lower cholesterol, such as simvastatin (Zocor), atorvastatin (Lipitor), and pravastatin (Pravachol); some blood pressure-lowering drugs, such as Nifediac…
Hyman, Phelps, & McNamara, PC | Patient Power in Orphan DrugsLinex Legal (press release) (registration)The LAM Foundation helped arrange funding and subjects for a pivotal clinical trial to study sirolimus, a drug approved to prevent renal transpla…
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new …7thSpace Interactive (press release)New onset diabetes mellitus (NODM) and acute rejection (AR) are important causes of morbidity and risk factors for allograft failure aft…
|
RPB honors Mass. Eye and Ear ophthalmologist with Senior Scientific …
News-Medical.net “I am delighted to have received this support from RPB, which will aid us tremendously in our investigations of ocular surface inflammation in eyes deemed at high risk of corneal transplant rejection,” said Dr. Dana. “With this support, we will be able … |